drugset

drugset / Trial / NCT00522470

Effects of Rosiglitazone on Serum Ghrelin and Peptide YY Levels

NCT00522470 ↗

Phase 4 Completed Baskent University

RandomizedParallel-groupOpen-label

Summary

We aimed to evaluate the effects of rosiglitazone on serum ghrelin and peptide yy levels in diabetic women.

Timeline

Start: —
Primary completion: —
Completion: —

Publications

Berberoglu Z, Yazici AC, Bayraktar N, Demirag NG. Rosiglitazone decreases fasting plasma peptide YY3-36 in type 2 diabetic women: a possible role in weight gain? Acta Diabetol. 2012 Dec;49 Suppl 1:S115-22. doi: 10.1007/s00592-011-0352-3. Epub 2011 Nov 19.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Rosiglitazone	Small molecule	4 mg	—

Indications